The effect of pulmonary rehabilitation (PR) on anxiety and depression symptoms in bronchiectasis: a propensity-matched study Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019
Impact of rehabilitation on the muscle strength and exercise tolerance in patients with interstitial pneumonia under steroid therapy Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018
Dyspnea-related anxiety versus dyspnea intensity during exercise in patients with COPD Source: Annual Congress 2007 - Effects of training in rehabilitation Year: 2007
The distinctive effect of fatigue in defining exercise intolerance and depression in moderate stable COPD, Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009
The long-term effects of dyspnoea self-management education and three doses of exercise on the anxiety related to dyspnoea Source: Eur Respir J 2001; 18: Suppl. 33, 173s Year: 2001
An evaluation of the effects of cognitive behavioural therapy on quality of life and anxiety and depression in COPD patients undergoing pulmonary rehabilitation Source: Eur Respir J 2007; 30: Suppl. 51, 95s Year: 2007
The effects of anxiety and depression on treatment adherence in COPD patients Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
A targeted intervention for depression initiated during pulmonary rehabilitation improves adherence to exercise, mood and dyspnea after acute exacerbation of COPD (AECOPD) Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013
The effects of respiratory muscle training on exercise performance and dyspnea in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002
Sertraline effects on dyspnea in patients with severe COPD Source: Eur Respir J 2005; 26: Suppl. 49, 288s Year: 2005
Prolonged effect of exacerbations on fatigue and depression in moderate clinically stable COPD Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010
Impact of fatigue improvement after pulmonary rehabilitation education on the long-term prognosis of patients with COPD Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018
Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
The impact of fatigue intensity on exercise capacity is persistently more dominant than dyspnoea in moderate COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
Early experiences of rehabilitation for patients post-COVID to improve fatigue, breathlessness exercise capacity and cognition. Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021
Inspiratory muscle performance predicts response to physical therapy in patients with chronic low back pain Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017
COPD patients with low adherence to specific exercise protocols benefit less from rehabilitation Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007
Fear-avoidance beliefs, exercise capacity, and activity-related dyspnea during pulmonary rehabilitation in patients with COPD Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
The effect of smoking on chemotherapy related nausea and vomiting in cancer patients Source: Annual Congress 2008 - Tobacco smoking by population subgroups Year: 2008
Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact Source: Eur Respir J, 52 (2) 1702637; 10.1183/13993003.02637-2017 Year: 2018